1. Home
  2. RSLS
  3. RSLS News

Latest ReShape Lifesciences Inc. (RSLS) News on June 3, 2025

ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update
RSLS

GlobeNewswire

13 days ago

ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split
RSLS

GlobeNewswire

a month ago

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split

ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
RSLS

GlobeNewswire

a month ago

ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium

ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
RSLS

GlobeNewswire

a month ago

ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
RSLS

GlobeNewswire

a month ago

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology

ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
RSLS

GlobeNewswire

2 months ago

ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market

ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
RSLS

GlobeNewswire

2 months ago

ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update

ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
RSLS

GlobeNewswire

3 months ago

ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology

ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
RSLS

GlobeNewswire

3 months ago

ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
RSLS

GlobeNewswire

4 months ago

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
RSLS

GlobeNewswire

4 months ago

ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
RSLS

GlobeNewswire

5 months ago

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
RSLS

GlobeNewswire

7 months ago

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
RSLS

GlobeNewswire

7 months ago

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
RSLS

GlobeNewswire

7 months ago

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology
RSLS

GlobeNewswire

7 months ago

ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology

Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested
RSLS

TipRanks

8 months ago

Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
RSLS

GlobeNewswire

8 months ago

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
RSLS

GlobeNewswire

10 months ago

ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update

ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
RSLS

GlobeNewswire

10 months ago

ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
RSLS

GlobeNewswire

a year ago

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”

ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

RSLS

Business Wire

a year ago

Net Asset Value(s)

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%
RSLS

GlobeNewswire

a year ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

Dstny honored with 'Employee Wellbeing Award'
RSLS

PR Newswire

a year ago

Dstny honored with 'Employee Wellbeing Award'

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
RSLS

GlobeNewswire

a year ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence
RSLS

Business Wire

a year ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon
RSLS

Newsfile

a year ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024
RSLS

PR Newswire

a year ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities
RSLS

Business Wire

a year ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Italian energy company targets Britain for fleet of 20 mini-nukes
RSLS

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
RSLS

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North
RSLS

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
RSLS

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations
RSLS

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
RSLS

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
RSLS

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled
RSLS

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

Lotto 6/49 - $64 million up for grabs in the next draw!
RSLS

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
RSLS

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
RSLS

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
RSLS

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
RSLS

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
RSLS

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
RSLS

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
RSLS

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

RSLS

GuruFocus.com

a year ago

Reshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update

ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

ReShape Lifesciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
RSLS

Simply Wall St.

a year ago

ReShape Lifesciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX

ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2023
RSLS

PR Newswire

a year ago

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2023

ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX

S&W Seed Company to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
RSLS

PR Newswire

a year ago

S&W Seed Company to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Cyngn Increases Commercialization of AI-Powered Autonomous Vehicle Solutions in 2023
RSLS

PR Newswire

a year ago

Cyngn Increases Commercialization of AI-Powered Autonomous Vehicle Solutions in 2023

Paragon Calls Out OPT’s Inaccurate Statements About Voting on the Blue Proxy Card; Vote the Blue Proxy Card and Put an End to the Corporate Greed and Drowning Share Price
RSLS

ACCESSWIRE

a year ago

Paragon Calls Out OPT’s Inaccurate Statements About Voting on the Blue Proxy Card; Vote the Blue Proxy Card and Put an End to the Corporate Greed and Drowning Share Price

FingerMotion Provides Supplemental Quarterly Guidance
RSLS

ACCESSWIRE

a year ago

FingerMotion Provides Supplemental Quarterly Guidance

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
RSLS

PR Newswire

a year ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

20 Countries with the Highest Plastic Surgery Rates per Capita
RSLS

Insider Monkey

a year ago

20 Countries with the Highest Plastic Surgery Rates per Capita

Cyngn to Present at the Sequire Investor Summit in Puerto Rico
RSLS

PR Newswire

a year ago

Cyngn to Present at the Sequire Investor Summit in Puerto Rico

Lilium Announces Planned Participation in Upcoming First Quarter 2024 Investor Events
RSLS

GlobeNewswire

a year ago

Lilium Announces Planned Participation in Upcoming First Quarter 2024 Investor Events

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
RSLS

GlobeNewswire

a year ago

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
RSLS

GlobeNewswire

a year ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA

Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
RSLS

GlobeNewswire

a year ago

Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024

Burning Rock Announces Receipt of Notification from NASDAQ
RSLS

GlobeNewswire

a year ago

Burning Rock Announces Receipt of Notification from NASDAQ

SELLAS Life Sciences Announces Proposed Public Offering
RSLS

GlobeNewswire

a year ago

SELLAS Life Sciences Announces Proposed Public Offering

Kopin to Ring Nasdaq Closing Bell on January 16th
RSLS

Business Wire

a year ago

Kopin to Ring Nasdaq Closing Bell on January 16th

11 Cheap Pot Stocks to Buy
RSLS

Insider Monkey

a year ago

11 Cheap Pot Stocks to Buy

RSLS

News Direct

a year ago

ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex

ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors
RSLS

PR Newswire

a year ago

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
RSLS

GlobeNewswire

a year ago

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

An Intrinsic Calculation For Beasley Broadcast Group, Inc. (NASDAQ:BBGI) Suggests It's 29% Undervalued
RSLS

Simply Wall St.

a year ago

An Intrinsic Calculation For Beasley Broadcast Group, Inc. (NASDAQ:BBGI) Suggests It's 29% Undervalued

ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
RSLS

GlobeNewswire

a year ago

ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
RSLS

GlobeNewswire

a year ago

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock

We're A Little Worried About NeuroSense Therapeutics' (NASDAQ:NRSN) Cash Burn Rate
RSLS

Simply Wall St.

a year ago

We're A Little Worried About NeuroSense Therapeutics' (NASDAQ:NRSN) Cash Burn Rate

Gain Therapeutics to Participate in AI Driven Drug Discovery Summit
RSLS

GlobeNewswire

2 years ago

Gain Therapeutics to Participate in AI Driven Drug Discovery Summit

7 Under-$10 Names to Put in Your Christmas Stocking
RSLS

InvestorPlace

2 years ago

7 Under-$10 Names to Put in Your Christmas Stocking

QReal Creates Immersive SNAP Lens for KillaBears, Demonstrating Extraordinary Activation Activity
RSLS

ACCESSWIRE

2 years ago

QReal Creates Immersive SNAP Lens for KillaBears, Demonstrating Extraordinary Activation Activity

ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
RSLS

GlobeNewswire

2 years ago

ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds

NeurAxis Announces CareFirst BCBS Policy Coverage
RSLS

GlobeNewswire

2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Americas Gold and Silver Reports Q3-2023 Results
RSLS

Business Wire

2 years ago

Americas Gold and Silver Reports Q3-2023 Results

RSLS

South China Morning Post

2 years ago

Lufax to acquire Hong Kong virtual lender Ping An OneConnect Bank for US$119.5 million

Saba Capital Management, L.P. Bolsters Portfolio with DWS Strategic Municipal Income Trust Shares
RSLS

GuruFocus.com

2 years ago

Saba Capital Management, L.P. Bolsters Portfolio with DWS Strategic Municipal Income Trust Shares

OneConnect Announces Third Quarter and Nine Months Ended September 30, 2023 Unaudited Financial Results
RSLS

PR Newswire

2 years ago

OneConnect Announces Third Quarter and Nine Months Ended September 30, 2023 Unaudited Financial Results

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024
RSLS

GlobeNewswire

2 years ago

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024

Leverage Extended for DWS Municipal Income Trust and DWS Strategic Municipal Income Trust
RSLS

Business Wire

2 years ago

Leverage Extended for DWS Municipal Income Trust and DWS Strategic Municipal Income Trust

Hurco Companies, Inc. Announces Quarterly Cash Dividend
RSLS

GlobeNewswire

2 years ago

Hurco Companies, Inc. Announces Quarterly Cash Dividend

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023
RSLS

GlobeNewswire

2 years ago

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023

Strong Global Entertainment Reports Third Quarter 2023 Operating Results
RSLS

GlobeNewswire

2 years ago

Strong Global Entertainment Reports Third Quarter 2023 Operating Results

RSLS

GuruFocus.com

2 years ago

Monte Rosa Therapeutics Inc (GLUE) Reports Q3 2023 Financial Results and Strategic Developments

RSLS

Associated Press Finance

2 years ago

Monte Rosa Therapeutics: Q3 Earnings Snapshot

Monte Rosa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
RSLS

GlobeNewswire

2 years ago

Monte Rosa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
RSLS

GlobeNewswire

2 years ago

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan

RSLS

PR Newswire

2 years ago

OneConnect to Announce Third Quarter 2023 Financial Results

Share on Social Networks: